Skip to main content
. 2020 Jul 30;11(7):604. doi: 10.1038/s41419-020-02804-3

Fig. 1. Elevated EN2 expression is associated with colorectal cancer progression.

Fig. 1

a The expression of EN1 (left) and EN2 (right) in CRC samples in GSE9348 dataset. b The expression of EN2 in CRC samples in GTEx and TCGA dataset. c, d The expression of EN2 analyzed by qRT-PCR (b) and western blotting (c) in CRC samples and adjacent normal colorectal samples. e, f The expression of EN2 analyzed by qRT-PCR (d) and western blotting (e) in 8401 and CRC cell lines. g The protein expression of EN2 detected by immunohistochemistry (IHC) in CRC and adjacent normal colorectal samples. Right is the quantification data for IHC. Top: original magnification, ×100. Scale bar: 100 µm; Bottom: original magnification, ×200. Scale bar: 50 µm. h Kaplan–Meier analysis of the overall survival rate of 165 CRC patients with low or high expression level of EN2. i Univariate and multivariate Cox regression analysis of different prognostic factors in CRC patients. j Receiver operating characteristic (ROC) curves for detecting CRC patients in GSE9348. Data are presented as mean ± SEM from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ns no significance.